LUNGevity Foundation/LinkedIn
May 10, 2025, 17:43
LUNGevity Foundation: Upal Basu Roy on progress in Small Cell Lung Cancer research
LUNGevity Foundation shared a post on LinkedIn:
“It’s important to acknowledge that this progress in treating SCLC is possible because of the support from nonprofits, such as LUNGevity, and of course, federal agencies. We are deeply grateful to the National Cancer Institute for investing in SCLC research through the Recalcitrant Cancer Research Act of 2013.
The investment by the NCI and the work of an international community of patients and their families, along with scientists and doctors, have made the progress we are seeing today possible.
-Upal Basu Roy, PhD, MPH, Executive Director of Research at LUNGevity “
Read ‘Small Cell Lung Cancer: The Dial Is Starting to Move’ and ‘Hot Topic Highlights: 2025 Small Cell Lung Cancer Meeting’.
More posts featuring Upal Basu Roy on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 29, 2025, 22:26
May 29, 2025, 21:09